Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 16, 2020
High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation
Simon Pape, Tom J G Gevers, Jan Maarten Vrolijk, et al.
Endoscopy
|
April 10, 2025
Endoscopic ultrasound-guided choledochoduodenostomy results in fewer complications than percutaneous drainage following failed ERCP in malignant distal biliary obstruction
Mike J P de Jong, Foke van Delft, Erwin-Jan M van Geenen, et al.
Scandinavian Journal of Gastroenterology
|
August 16, 2014
Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands
Nicole M F van Gerven, Bart J Verwer, Birgit I Witte, et al.
Journal of Hepatology
|
December 15, 2023
An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis
Romée J A L M Snijders, Anna E C Stoelinga, Tom J G Gevers, et al.
Trials
|
December 13, 2022
Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial
Romée J A L M Snijders, Anna E C Stoelinga, Tom J G Gevers, et al.
JHEP Reports : Innovation in Hepatology
|
August 8, 2024
Incidence and prevalence of primary biliary cholangitis in the Netherlands - A nationwide cohort study
Rozanne C de Veer, Maria C B van Hooff, Ellen Werner, et al.
Trials
|
February 14, 2026
Antibiotic treatment for 1 day versus 4-7 days in patients with acute cholangitis after adequate endoscopic biliary drainage (COBRA): study protocol for a randomized controlled trial
Anouk G Overdevest, Elske Sieswerda, Sylke Haal, et al.
Alimentary Pharmacology & Therapeutics
|
April 14, 2026
A Nationwide Assessment of Anticholestatic Therapy Uptake in Patients With Primary Biliary Cholangitis: Opportunities for Optimisation
Ellen Werner, Maria C B van Hooff, Gemma H X Weijsters, et al.
Trials
|
April 3, 2018
Fluid hydration to prevent post-ERCP pancreatitis in average- to high-risk patients receiving prophylactic rectal NSAIDs (FLUYT trial): study protocol for a randomized controlled trial
Xavier J N M Smeets, David W da Costa, Paul Fockens, et al.
The Lancet. Gastroenterology & Hepatology
|
March 19, 2021
Aggressive fluid hydration plus non-steroidal anti-inflammatory drugs versus non-steroidal anti-inflammatory drugs alone for post-endoscopic retrograde cholangiopancreatography pancreatitis (FLUYT): a multicentre, open-label, randomised, controlled trial
Christina J Sperna Weiland, Xavier J N M Smeets, Wietske Kievit, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 16, 2020
High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation
Simon Pape, Tom J G Gevers, Jan Maarten Vrolijk, et al.
Endoscopy
|
April 10, 2025
Endoscopic ultrasound-guided choledochoduodenostomy results in fewer complications than percutaneous drainage following failed ERCP in malignant distal biliary obstruction
Mike J P de Jong, Foke van Delft, Erwin-Jan M van Geenen, et al.
Scandinavian Journal of Gastroenterology
|
August 16, 2014
Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands
Nicole M F van Gerven, Bart J Verwer, Birgit I Witte, et al.
Journal of Hepatology
|
December 15, 2023
An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis
Romée J A L M Snijders, Anna E C Stoelinga, Tom J G Gevers, et al.
Trials
|
December 13, 2022
Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial
Romée J A L M Snijders, Anna E C Stoelinga, Tom J G Gevers, et al.
JHEP Reports : Innovation in Hepatology
|
August 8, 2024
Incidence and prevalence of primary biliary cholangitis in the Netherlands - A nationwide cohort study
Rozanne C de Veer, Maria C B van Hooff, Ellen Werner, et al.
Trials
|
February 14, 2026
Antibiotic treatment for 1 day versus 4-7 days in patients with acute cholangitis after adequate endoscopic biliary drainage (COBRA): study protocol for a randomized controlled trial
Anouk G Overdevest, Elske Sieswerda, Sylke Haal, et al.
Alimentary Pharmacology & Therapeutics
|
April 14, 2026
A Nationwide Assessment of Anticholestatic Therapy Uptake in Patients With Primary Biliary Cholangitis: Opportunities for Optimisation
Ellen Werner, Maria C B van Hooff, Gemma H X Weijsters, et al.
Trials
|
April 3, 2018
Fluid hydration to prevent post-ERCP pancreatitis in average- to high-risk patients receiving prophylactic rectal NSAIDs (FLUYT trial): study protocol for a randomized controlled trial
Xavier J N M Smeets, David W da Costa, Paul Fockens, et al.
The Lancet. Gastroenterology & Hepatology
|
March 19, 2021
Aggressive fluid hydration plus non-steroidal anti-inflammatory drugs versus non-steroidal anti-inflammatory drugs alone for post-endoscopic retrograde cholangiopancreatography pancreatitis (FLUYT): a multicentre, open-label, randomised, controlled trial
Christina J Sperna Weiland, Xavier J N M Smeets, Wietske Kievit, et al.
Page
of 2